Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Nicole E Smolinski; Ruba Sajdeya; Robert Cook; Yan Wang; Almut G Winterstein; Amie Goodin

doi:10.1159/000527080

Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference

Med Cannabis Cannabinoids. 2022 Oct 17;5(1):138-141. doi: 10.1159/000527080. eCollection 2022 Jan-Dec.

Authors

Nicole E Smolinski^{1

2

3}, Ruba Sajdeya^{3

4}, Robert Cook^{3

4

5}, Yan Wang^{3

4}, Almut G Winterstein^{1

2

3}, Amie Goodin^{1

2

3}

Affiliations

¹ Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida, USA.
² Center for Drug Evaluation and Safety (CoDES), University of Florida, Gainesville, Florida, USA.
³ Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
⁴ Department of Epidemiology, University of Florida, Gainesville, Florida, USA.
⁵ College of Medicine, University of Florida, Gainesville, Florida, USA.

Abstract

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.

Keywords: Cannabidiol; Cannabinoids; Cannabis; Cannabis clinical outcomes research conference; Conference proceedings; Marijuana clinical outcomes; Marijuana efficacy; Medical marijuana.

Grants and funding

This work was funded by the Florida state legislature through the Consortium for Medical Marijuana Clinical Outcomes Research. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.